Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Español Near me My list Help
US Patient GuideUSA
Surprise me
Prescription medicine · generic available

Succinylcholine

Brand names: Anectine, Quelicin

Also listed by the FDA as: succinylcholine chloride · succinylcholine chloride dihydrate

Full FDA label All drugs

Official FDA data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the drug label, the NDC Directory, Drugs@FDA, recall reports and the drug shortage list. Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

At a glance

YesBoxed warning
To be discontinuedFDA shortage list
5Recalls (FDA reports)
27Companies
1952First FDA approval on file

Quick answers

What is Succinylcholine used for?
The FDA-approved label (Anectine, Sandoz Inc, November 29, 2023) says: “ANECTINE is indicated in adults and pediatric patients: • as an adjunct to general anesthesia • to facilitate tracheal intubation • to provide skeletal muscle relaxation during surgery or mechanical ventilation. ANECTINE is a depolarizing neuromuscular blocker indicated in adults and pediatric patients …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Does Succinylcholine have a boxed warning?
Yes. The FDA label for Anectine has a boxed warning, the FDA’s strongest warning. Read it on the full label and ask your pharmacist.
Is there a shortage of Succinylcholine?
The FDA drug shortage list shows “To be discontinued” for a product of this medicine (updated July 23, 2026). Ask your pharmacist about alternatives.
Has Succinylcholine been recalled?
FDA enforcement reports list 5 recalls of products of this medicine; the newest started September 26, 2025 (Class II). A recall usually concerns specific lots, not every product.
Who makes Succinylcholine?
27 companies list prescription products of Succinylcholine in the FDA NDC Directory, including Medical Purchasing Solutions, LLC, Fresenius Kabi USA, LLC and Meitheal Pharmaceuticals Inc..

What Succinylcholine is used for

Quoted from the “Indications and Usage” section of the FDA-approved label.

ANECTINE is indicated in adults and pediatric patients: • as an adjunct to general anesthesia • to facilitate tracheal intubation • to provide skeletal muscle relaxation during surgery or mechanical ventilation. ANECTINE is a depolarizing neuromuscular blocker indicated in adults and pediatric patients …

— FDA label: Anectine, Sandoz Inc, effective November 29, 2023. Read the full label on DailyMed →

The FDA has 38 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

Boxed warning

A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.

This label has a boxed warning. Read it on the full label →

37 of 38 FDA labels for this medicine have a boxed warning.

Forms and how it is given

Dosage formsInjection, solution · Injection
RouteIntramuscular · Intravenous · Parenteral
Prescription products38 in the FDA NDC Directory
Brand namesAnectine, Quelicin

Companies that list this medicine

Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.

FDA approval history

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
Brand and biologic applications
ApplicationSponsorApprovedLater changes approved
NDA008453
ANECTINE		 SandozAugust 20, 1952 24, latest November 21, 2023
2023: Labeling · 2022: Labeling · 2020: Labeling
NDA008845
QUELICIN, QUELICIN PRESERVATIVE FREE		 HospiraMay 1, 1953 47, latest November 1, 2022
2022: Labeling · 2022: Labeling · 2021: Labeling

Generic approvals (20)

Shortage status

To be discontinued · updated July 23, 2026 · first posted July 23, 2026

ProductSuccinylcholine Chloride, Injection, 20 mg/1 mL (NDC 63323-943-10)
CompanyFresenius Kabi USA, LLC

Ask your pharmacist whether your product is affected and what the options are.

FDA Drug Shortages database →

Recalls

From FDA enforcement reports, matched by the product’s NDC code. A recall usually covers specific lots only: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.

  1. September 26, 2025 · Class II · Ongoing · D-0008-2026

    Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.

    Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, For Intravenous or Intramuscular use, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540. NDC: 43598 — Dr. Reddy's Laboratories, Inc.

  2. August 27, 2025 · Class II · Ongoing · D-0623-2025

    Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity.

    Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL), Rx only, 10 mL Multiple-dose Vial, Sterile, Manufactured by Zydus Lifesciences Ltd, Vadodara, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Penn — Zydus Pharmaceuticals (USA) Inc

  3. June 15, 2017 · Class II · Terminated · D-1048-2017

    Lack of Sterility Assurance

    Succinylcholine Chloride Injection, USP 200 mg (20 mg/mL) Quelicin Multiple-dose vial, 10 mL, For I.V. or I.M. use. a.) one vial (NDC: 0409-6629-02), b.) 25 vial carton (NDC: 0409-6629-25). — Hospira a Pfizer Company

  4. March 15, 2016 · Class III · Ongoing · D-0836-2016

    Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for the lot number and/or expiration date to be faded or missing from the primary label on the glass vial.

    Quelicin (Succinylcholine Chloride) Injection, USP 200 mg. (20 mg/mL), 10 mL Multiple-dose vial, packaged in 25 Unit vials per carton, Rx only, HOSPIRA, INC., LAKE FOREST, IL 60045 USA, NDC 0409-6629-02 — Hospira Inc.

  5. February 26, 2013 · Class II · Terminated · D-315-2013

    Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.

    QUELICIN (succinylcholine chloride) Injection, USP, 200 mg (20 mg/mL) 10 mL, Rx only, HOSPIRA, INC. LAKE FOREST, IL 60045 USA, , NDC 0409-6629-02 — Hospira Inc.

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Official identifiers

RxCUI (RxNorm)1594589, 1594591, 1594593, 2598128, 2694114
SPL set ID of the quoted labela1e5d29f-111e-4a44-addf-beeb6ea81711
FDA labels (SPL)38
FDA applicationsNDA008453, NDA008845, 20 ANDA
Active ingredients (FDA)SUCCINYLCHOLINE

Sources

  1. FDA-approved label on DailyMed (National Library of Medicine) — Anectine, Sandoz Inc, effective November 29, 2023; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
  2. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026

openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →

Report an error → · Information for medicine makers